Keyphrases
Survival Outcomes
100%
Hodgkin Lymphoma Survivors
100%
Prognostic Factor Analysis
100%
T-AML
100%
Non-Hodgkin Lymphoma
53%
Overall Survival
38%
Chemotherapy
30%
Standardized Incidence Ratio
23%
Multivariate Analysis
15%
5-year Survival
15%
High Incidence
7%
Univariate Analysis
7%
Overall Survival of Patients
7%
Excess Risk
7%
Log-rank Test
7%
Lymphoma Patients
7%
Surveillance Epidemiology
7%
Serious Complications
7%
Year of Diagnosis
7%
End Results Database
7%
Development Risk
7%
Lymphoma Diagnosis
7%
Multiple Primary
7%
Database Study
7%
Background Therapy
7%
Medicine and Dentistry
Non-Hodgkin Lymphoma
100%
Prognostic Factor
100%
Factor Analysis
100%
Acute Myeloid Leukemia
100%
Overall Survival
61%
Patient with Non-Hodgkins Lymphoma
23%
Standardized Incidence Ratio
23%
Multivariate Analysis
15%
De Novo Acute Myeloid Leukemia
15%
Univariate Analysis
7%
Log Rank Test
7%
Surveillance, Epidemiology, and End Results
7%
Pharmacology, Toxicology and Pharmaceutical Science
Nonhodgkin Lymphoma
100%
Acute Myeloid Leukemia
100%
Overall Survival
61%
Chemotherapy
30%
Standardized Incidence Ratio
23%
De Novo Acute Myeloid Leukemia
15%